XML 16 R4.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED STATEMENTS OF INCOME (LOSS) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Income Statement [Abstract]        
Net sales $ 267,021 $ 243,975 $ 796,259 $ 705,871
Cost of sales 146,527 141,961 439,732 415,857
Gross profit 120,494 102,014 356,527 290,014
Operating expenses:        
Selling, general and administrative 86,474 72,215 259,061 217,790
Research and development 16,974 13,506 50,841 42,404
Legal settlement       18,200
Impairment charges 0 20,585 4,283 28,305
Contingent consideration expense (benefit) 1,115 (4,356) 3,322 884
Total operating expenses 104,563 101,950 317,507 307,583
Income (loss) from operations 15,931 64 39,020 (17,569)
Other income (expense):        
Interest income 104 67 668 234
Interest expense (1,233) (2,197) (4,156) (8,056)
Other expense - net (625) (118) (1,796) (1,085)
Total other expense - net (1,754) (2,248) (5,284) (8,907)
Income (loss) before income taxes 14,177 (2,184) 33,736 (26,476)
Income tax expense (benefit) 2,210 825 5,895 (1,255)
Net income (loss) $ 11,967 $ (3,009) $ 27,841 $ (25,221)
Earnings (loss) per common share        
Basic (in dollars per share) $ 0.21 $ (0.05) $ 0.50 $ (0.46)
Diluted (in dollars per share) $ 0.21 $ (0.05) $ 0.49 $ (0.46)
Weighted average shares outstanding        
Basic (in shares) 56,302 55,505 56,033 55,386
Diluted (in shares) 57,549 55,505 57,274 55,386